Cilostazol detailed information: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
|||
| Line 12: | Line 12: | ||
==US Brand Names== | ==US Brand Names== | ||
'''PLETAL<sup>®</sup>''' | '''PLETAL<sup>®</sup>, Cilostazol<sup>®</sup>.''' | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
Revision as of 15:38, 28 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
For patient information, click here.
Overview
Category
US Brand Names
PLETAL®, Cilostazol®.
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages